About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)

Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)

NCT01140048·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Organon and Co

Age

1–6

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

successfully completed MK-0476 Protocol 272
had RSV-induced bronchiolitis at entry into Protocol 272

You may not be if

had developed or had been diagnosed with any illness or congenital disorder that could be immediately life threatening

The record

StatusCompleted

PhaseNo phase

Taking part343

StartedOct 2007

UpdatedFeb 2, 2022

Conditions

Respiratory Syncytial Virus Bronchiolitis